NCT04912440

Brief Summary

Patients with surgically altered anatomy receiving Motorized Spiral Eneroscopy (MSE)-assisted ERCP at a single endoscopic reference center for various indications are planned to be retrospectively enrolled

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

3 months

First QC Date

May 28, 2021

Last Update Submit

June 18, 2021

Conditions

Keywords

endoscopyenteroscopyercp in altered anatomy

Outcome Measures

Primary Outcomes (2)

  • Success rate of MSE-ERCP

    rate of subjects with successfull MSE-assisted ERCP

    intraprocedural

  • Adverse event rate of MSE-ERCP

    rate of adverse events during and early after MSE-ERCP

    3 days

Secondary Outcomes (2)

  • Success rate of enteroscopy

    intraprocedural

  • Procedural duration

    intraprocedural

Study Arms (1)

MSE-ERCP

Group of patients, that received motorized spiral enteroscopy assisted ERCP in altered anatomy at the single study center

Device: MSE-ERCP

Interventions

MSE-ERCPDEVICE

No interventional study, MSE-ERCP performed within routine treatment, (approved indication of device)

MSE-ERCP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with surgically altered upper gastrointestinal anatomy and indication for endoscopic retrograde cholangio-pancreatography

You may qualify if:

  • altered upper gastrointestinal anatomy after Billroth-II- or Roux-en-Y reconstructive surgery
  • indication for ERCP with biliary and/or pancreatic indication
  • Enteroscopy-assisted ERCP using MSE, at the study center during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Evangelisches Krankenhaus

Düsseldorf, 40217, Germany

Location

Study Officials

  • Torsten Beyna, MD PhD

    Evangelisches Krankenhaus Düsseldorf, Department of Gastroenterology and Therapeutic Endoscopy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2021

First Posted

June 3, 2021

Study Start

June 1, 2021

Primary Completion

September 1, 2021

Study Completion

October 1, 2021

Last Updated

June 21, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

No exchange of individual data is planned

Locations